Luminec Life Sciences is spearheading a groundbreaking project that will have an impact on millions of people suffering from a variety of disorders. Three people, representing three different conditions, are being treated using the science of Luminec Pharmaceuticals, which has combined the formulations Triamino™ & TAFA400™ based on the Schutt Paradigm of Free Amino Alignment & Molecular Stability, along with a customized nutrition program to enhance their immune systems to maximum levels for pre- and post-op stem cell therapy.